{"id":"507fabb9-64cd-4561-9d52-4f536c2aaf09","companyId":"55a81e13-fb85-4bd8-8951-c16d2bd50eff","modelName":"Aletta","slug":"vitestro-aletta","description":"Aletta is Vitestro's autonomous robotic phlebotomy device, combining AI, ultrasound imaging, and robotics to identify a suitable vein, guide needle insertion, and collect diagnostic blood samples; clinical trials reported about 94.5% first-stick success, with EU MDR approval.","formFactor":"service","industryVertical":null,"environment":null,"maturityStage":"research","lifecycleState":"active","supersededByModelId":null,"specs":{"class":"autonomous robotic phlebotomy device","success":"~94.5% first-stick"},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://vitestro.com/aletta/","sourceName":"Vitestro"},{"url":"https://www.fda.gov/news-events/press-announcements/fda-authorizes-first-its-kind-robotic-blood-draw-device","title":"FDA authorizes first-of-its-kind robotic blood draw device","sourceName":"U.S. Food and Drug Administration"},{"url":"https://www.instagram.com/reel/Dd4S8z6gytB/","title":"Vitestro Aletta drawing blood from real patients; NIR/ultrasound/Doppler (uncover.robotics via Instagram)","sourceName":"Instagram (@uncover.robotics / via Deploy.Report digest)","publishedAt":"2026-09-29"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[{"label":"Autonomy level","value":"Autonomous"},{"label":"Sensor suite","value":"AI and ultrasound imaging"},{"label":"First-stick success","value":"~94.5%"},{"label":"Regulatory approval","value":"EU MDR"},{"label":"End-to-end robotic blood draw","value":"Vitestro describes Aletta as an autonomous device that identifies a vein, inserts the needle, and collects blood into tubes for diagnostic testing ([Vitestro Aletta](https://vitestro.com/aletta/)).","sourceUrl":"https://vitestro.com/aletta/"},{"label":"US authorization","value":"The FDA announced De Novo authorization for Vitestro's autonomous robotic blood-draw device, the first of its kind authorized for the stated outpatient use ([FDA robotic blood draw](https://www.fda.gov/news-events/press-announcements/fda-authorizes-first-its-kind-robotic-blood-draw-device)).","sourceUrl":"https://www.fda.gov/news-events/press-announcements/fda-authorizes-first-its-kind-robotic-blood-draw-device"}],"createdAt":"2026-06-24T05:34:01.855Z","updatedAt":"2026-09-30T14:56:44.318Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":"autonomous","autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"jsonLd":{"@context":"https://schema.org","@type":"Product","@id":"https://registry.deploy.report/models/vitestro-aletta","url":"https://registry.deploy.report/models/vitestro-aletta","name":"Aletta","description":"Aletta is Vitestro's autonomous robotic phlebotomy device, combining AI, ultrasound imaging, and robotics to identify a suitable vein, guide needle insertion, and collect diagnostic blood samples; clinical trials reported about 94.5% first-stick success, with EU MDR approval.","identifier":"507fabb9-64cd-4561-9d52-4f536c2aaf09","category":"service","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"research","lifecycle_state":"active","architectural_position":{"cohort":"service","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":3,"primary_source_types":["primary-fda-database"]}}}